Loading Peptellect…
Loading Peptellect…
Blends · Klow80
£186.99excl. VAT
80 mg totalFree vial: order any 3 vials and the lowest-priced one is free.
For laboratory research use only. Not for human or veterinary use. Not for consumption, administration, diagnosis, treatment, or prevention of disease.
KLOW names four components: GHK-Cu, BPC-157, TB-500 and KPV.
Overview and specificationsKLOW names four components: GHK-Cu, BPC-157, TB-500 and KPV. A total blend mass is not a substitute for component-specific amounts. Individual peptide literature cannot resolve the missing composition information or establish the properties of the finished blend.
A blend is assessed through its individual constituents and the finished mixture. There is no single molecular formula or molecular weight that represents the entire vial. Component identity, component amounts and batch-specific analytical evidence should be reviewed together.
The supplied amount is 80 mg total; supplied ratio 10 / 10 / 10 / 50 mg; mapping unresolved. Batch identity, purity, storage and handling should be established from the material-specific COA and safety documentation before laboratory evaluation.
Reference chemistry describes a database compound. It is not a measurement or certification of the material in this vial.
Lingda Laboratory report LDA-2216-2364, issued 18 October 2026. Chromatographic purity (HPLC): >99.52% ± 0.18%. Quantity (HPLC): 80.68 mg. The certificate covers the batch tested; match the lot on your vial to it. Open full size
Match product identity and lot number first. Then review analytical methods, reported results, acceptance criteria and the issuing laboratory. A certificate for another batch does not establish this batch’s properties.
Use the SDS and batch documentation for the exact material, formulation and container. Storage and reconstitution instructions have not been confirmed for this entry; do not infer them from a similarly named product.
No. Materials are exclusively for laboratory research, not consumption, self-experimentation, human or veterinary administration, diagnosis, treatment or prevention of disease.
Unresolved identity, composition or analytical information requires clarification before a material can be evaluated for supply.
Scientific Advisory Board
Chaired by neuroscientist Dr Steve Ray, our Scientific Advisory Board brings decades of research in regenerative medicine and cell biology to the specifications we publish for every research compound.
